Loading company…
Nalagenetics, based in Singapore, offers personalized genetic tests covering nutrition, cancer risk and medication.
Founded in 2016 in Singapore, Nalagenetics Pte. Ltd. focuses on personalized genetic testing. Its products include MammoReady, NutriReady, RxReady and LifeReady, covering breast cancer risk, nutrition, medication response and wellness through non-invasive DNA testing. The company completed a Series B round in March 2022 raising USD 12.62 mn and has completed 4 deals in total. Founders Alexander Lezhava and Jianjun Liu established the company, which has a valuation of USD 33.30 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in